Related Experiment Video
Updated: Feb 8, 2026
07:30
Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
4.4K
Obesity Risk Factors in Patients After Kidney Transplantation
S Małgorzewicz1, P Wołoszyk2, A Chamienia2
1Department of Clinical Nutrition, Medical University of Gdańsk, Gdańsk, Poland.
Transplantation Proceedings
|June 26, 2018
Summary
A significant number of kidney transplant recipients (KTRs) have sarcopenic obesity, characterized by excess body weight and muscle loss. This condition is linked to dietary habits, including higher sugar and fruit intake.
Area of Science:
- Nephrology
- Transplantation Medicine
- Nutritional Science
Background:
- Kidney transplantation offers superior outcomes compared to dialysis for renal replacement therapy.
- Body composition may influence complications and survival in kidney transplant recipients (KTRs).
Purpose of the Study:
- To assess the eating habits and body composition of kidney transplant recipients.
- Investigate the prevalence of overweight, obesity, and sarcopenia in KTRs.
Main Methods:
- Seventy KTRs underwent anthropometry, body composition analysis (bioimpedance, dynamometry), and dietary assessment (Food Frequency Questionnaire - FFQ6).
- Biochemical parameters were also evaluated.
Main Results:
- Overweight (33.8%) and obesity (21.1%) were prevalent in KTRs.
- High BMI correlated with increased body fat and waist circumference.
- Sarcopenia (decreased lean tissue index and handgrip strength) was identified in 33.3% of KTRs with excess body weight.
- KTRs with excess body mass showed significantly higher consumption of sugar and fruits.
Conclusions:
- A substantial proportion of KTRs exhibit sarcopenic obesity.
- Excess body weight in KTRs is multifactorial, influenced by immunosuppression, physical activity, and diet.
- Dietary assessment (FFQ6) suggests a link between carbohydrate intake and excess body weight in this population.
Related Concept Videos
01:26Factors Affecting the Risk of Infection
13.7K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.7K
01:21Drug Dosing: Obese Patients
269
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269
01:28Kidney Transplant I: Introduction
492
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
492
01:26Kidney Transplant II: Surgical Procedure
434
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
434
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
287
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
287
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
191
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
191